Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YETI study of immunity after yellow fever vaccination in travelers using immunosuppressive medication
NL-OMON20476Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Aug 2012
- Countries
- 1
01
Overview
Open-label trial in yellow fever (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Number of yellow fever specific CD8+ T cells in peripheral blood mononuclear cells. Started Aug 2012; status: active, not recruiting.
02
Conditions
yellow fever
Beyond the preview
Go deeper on NL-OMON20476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20476.